MilliporeSigma bioprocessing platform

The Facility of the Future

To make everything on a bioprocessing line—from development and materials through production to testing and analytics—run as a digitally managed system, all platforms must be integrated and controlled with automation and software.
tobacco field

Building Therapeutic Proteins through Plant Glycosylation: A Sweet Solution

The Fast Glycaneering process reportedly allows customized N-glycosylation to meet target profiles, specifically antibodies that harbor afucosylated humanized N-glycans (with increased ADCC) or humanized N-glycans.

Agennix Contracts Lonza for Commercial Manufacturing of Its Oral NSCLC Immunotherapy

Talactoferrin is in Phase III, and DSM is already on board as a producer.

Thermo Fisher to Acquire Brammer Bio for $1.7B, Expanding Gene Therapy Presence

Thermo Fisher Scientific has agreed to acquire Brammer Bio for $1.7 billion cash, the companies said, in a deal designed to increase the buyer’s presence in gene therapy with the viral vector contract development...

Amicus, Thermo Fisher’s Brammer Bio Partner on Gene Therapy Manufacturing

Amicus Therapeutics will address clinical and commercial supply needs for its intrathecal AAV Batten disease gene therapy programs by partnering with Thermo Fisher Scientific’s recently-acquired Brammer Bio.
908 Devices employees

The Rebel Accelerates Process-Development Cycles and Maximizes Bioreactor Utilization

908 Devices benchtop analyzer allows biopharma researchers to accelerate process-development cycles and maximize their bioreactor utilization by running media analysis at-line, anytime.
Thermo Fisher bioprocessing lab

Thermo Fisher Unveils Viral Vector Manufacturing Expansion

The company’s $6 million investment doubles the Alachua County Florida site’s laboratory and warehousing capacity for upstream process development and quality control testing of gene therapy products.
Vuzix Augmented Reality Glasss

Augmented-Reality Glasses Could Aid Manufacturing Quality Control

Sciar Company, which says its product could help manufacturers automatically log product samples and reagents and reduce the risk of errors in manual workflows, reports that the necessary applications for AR and cloud infrastructure for its software are already built but continue to be developed based on customer feedback from pilot studies.
protein synthesis and ribosome

Cell Out? Lysate-Based Expression an Option for Personalized Meds

Expert says a company seeking flexible ways of making high-value, low-volume products should try cell-free expression as the method requires minimal manufacturing infrastructure and process development requirements.

Critical Biologics to Use Scarab’s Clean Genome E. coli for Production of Phase II...

Firm claims bioengineered E. coli leads to fivefold increase in production yield of recombinant human protein.

Recently Featured

Scroll Up